The quiet rise of the clinical contractor

Article Abstract:

A large number of drug trials are being outsourced to contractors as drug companies feel it is a good way to cut down costs. Critics claim that the involvement of contractors makes the process secretive, when it should actually be transparent to the public, and worry that in their quest to deliver the data fast, the contractors might cut areas.

Use of services, Clinical trials, Outsourcing

---

Moment of reckoning

Article Abstract:

The impact of the new laws on the regulation of medicines on regulators, patients and the U.S. drug and biotechnology industries is examined. The Prescription Drug User Fee Act, expiring on September 2007, directs more than $300 million in fees from drug companies every year to pay for faster reviews from the Food and Drug Administration (FDA).

Legal issues & crime, Government regulation (cont), Government regulation, Legal/Government Regulation, Laws, regulations and rules, Political aspects, Medical policy, Health policy

---

Similar abstracts:

• Abstracts: Appetite downer awaits approval. Man on a mission. Race is on for flu vaccine
• Abstracts: Collective action and social capital of wildlife management associations. Spatiotemporal responses of reptiles and amphibians to timber harvest treatment
• Abstracts: Brute force in the clinic. The heart of the cycle
• Abstracts: Medicare compels heart patients to enlist in follow-up research
• Abstracts: The giving machine. Online resources threaten livelihood of libraries. Dollar and sense

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.